Myelofibrosis (MF) is a complex blood disorder characterized by an enlarged spleen, various blood cell abnormalities, and potential complications such as vascular issues and progression to a more aggressive phase. Diagnosing MF involves thorough assessments, including blood tests, bone marrow analysis, genetic evaluations, and understanding your medical history. At the American Society of Hematology (ASH) 2023, Passamonti and Mora provided an updated review of myelofibrosis and its secondary causes.
Secondary myelofibrosis (SMF) encompasses a range of conditions where the bone marrow's ability to produce blood cells is restricted, leading to fibrosis. Due to its multiple causes, it occurs more commonly than primary myelofibrosis.
Secondary Myelofibrosis is a result of previous damage to the bone marrow, for it to be considered secondary, there must be a health history of any of the following conditions:
Myelofibrosis is caused when fibroblasts (cells that create scar tissue) grow in the bone marrow, interfering with the blood supply and replacing blood-forming cells with inactive fibrous tissue. So, anything that can cause fibrous tissue to form in the bone marrow can potentially induce secondary myelofibrosis. To know more about the types of secondary myelofibrosis, we have a comprehensive article here.
If you want to receive updated information on myelofibrosis, you can create an account at HealthTree Cure Hub to participate in webinars, events, and more!
Myelofibrosis (MF) is a complex blood disorder characterized by an enlarged spleen, various blood cell abnormalities, and potential complications such as vascular issues and progression to a more aggressive phase. Diagnosing MF involves thorough assessments, including blood tests, bone marrow analysis, genetic evaluations, and understanding your medical history. At the American Society of Hematology (ASH) 2023, Passamonti and Mora provided an updated review of myelofibrosis and its secondary causes.
Secondary myelofibrosis (SMF) encompasses a range of conditions where the bone marrow's ability to produce blood cells is restricted, leading to fibrosis. Due to its multiple causes, it occurs more commonly than primary myelofibrosis.
Secondary Myelofibrosis is a result of previous damage to the bone marrow, for it to be considered secondary, there must be a health history of any of the following conditions:
Myelofibrosis is caused when fibroblasts (cells that create scar tissue) grow in the bone marrow, interfering with the blood supply and replacing blood-forming cells with inactive fibrous tissue. So, anything that can cause fibrous tissue to form in the bone marrow can potentially induce secondary myelofibrosis. To know more about the types of secondary myelofibrosis, we have a comprehensive article here.
If you want to receive updated information on myelofibrosis, you can create an account at HealthTree Cure Hub to participate in webinars, events, and more!
about the author
Jimena Vicencio
Jimena is an International Medical Graduate and a member of the HealthTree Writing team. She has a passion for languages and is currently learning Japanese. In her free time, she loves playing with her cats. Jimena is also pursuing a bachelor's degree in journalism.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.